125 related articles for article (PubMed ID: 25266748)
21. Cetuximab in metastatic colorectal cancer.
Broadbridge VT; Karapetis CS; Price TJ
Expert Rev Anticancer Ther; 2012 May; 12(5):555-65. PubMed ID: 22594891
[TBL] [Abstract][Full Text] [Related]
22. Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.
Lévi F; Karaboué A; Gorden L; Innominato PF; Saffroy R; Giacchetti S; Hauteville D; Guettier C; Adam R; Bouchahda M
Cancer Chemother Pharmacol; 2011 Feb; 67(2):339-48. PubMed ID: 20401611
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target.
Meropol NJ
J Clin Oncol; 2005 Mar; 23(9):1791-3. PubMed ID: 15677698
[No Abstract] [Full Text] [Related]
24. [Adverse effects of new oncologic therapies].
Weisshaupt Ch; Budak K; Pestalozzi B
Praxis (Bern 1994); 2011 Jul; 100(15):885-91; quiz 890. PubMed ID: 21792802
[No Abstract] [Full Text] [Related]
25. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view.
Battisti S; Guida FM; Pagliara E; Tonini G; Zobel BB; Santini D
Clin Colorectal Cancer; 2014 Sep; 13(3):e13-5. PubMed ID: 25085312
[No Abstract] [Full Text] [Related]
26. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
27. [Chemotherapy of colonic cancer].
Block S
Soins; 2010 Mar; (743):46. PubMed ID: 20423037
[No Abstract] [Full Text] [Related]
28. Adjuvant therapy for colon cancer: the European experience.
Wils J
Tumori; 2001; 87(1 Suppl 1):S85. PubMed ID: 11300039
[No Abstract] [Full Text] [Related]
29. Two new drugs for colon cancer.
Med Lett Drugs Ther; 2004 Jun; 46(1184):46-8. PubMed ID: 15184808
[No Abstract] [Full Text] [Related]
30. Improved first-line chemotherapy: a better chance for surgery?
Tejpar S; Van Cutsem E; Adam R
Lancet Oncol; 2010 Jan; 11(1):4-5. PubMed ID: 19942480
[No Abstract] [Full Text] [Related]
31. Images in clinical medicine. Cetuximab-associated acneiform eruption.
Moss JE; Burtness B
N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
[No Abstract] [Full Text] [Related]
32. EGFR antibodies in colorectal cancer: where do they belong?
Grothey A
J Clin Oncol; 2010 Nov; 28(31):4668-70. PubMed ID: 20921457
[No Abstract] [Full Text] [Related]
33. Accrual delayed in adjuvant bevacizumab trial.
Tuma RS
J Natl Cancer Inst; 2006 Apr; 98(7):439-40. PubMed ID: 16595779
[No Abstract] [Full Text] [Related]
34. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
de Melo JV; Vieira de Melo MS; Abad MH
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
[TBL] [Abstract][Full Text] [Related]
35. Reversible grade 4 hyperbilirubinemia in a patient with UGT1A1 7/7 genotype treated with irinotecan and cetuximab.
Gupta B; LeVea C; Litwin A; Fakih MG
Clin Colorectal Cancer; 2007 Mar; 6(6):447-9. PubMed ID: 17531109
[TBL] [Abstract][Full Text] [Related]
36. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
Cunningham D; Humblet Y; Siena S; Khayat D; Bleiberg H; Santoro A; Bets D; Mueser M; Harstrick A; Verslype C; Chau I; Van Cutsem E
N Engl J Med; 2004 Jul; 351(4):337-45. PubMed ID: 15269313
[TBL] [Abstract][Full Text] [Related]
37. Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
Cheng AL; Li J; Vaid AK; Ma BB; Teh C; Ahn JB; Bello M; Charoentum C; Chen LT; de Lima Lopes G; Ho GF; Kong HL; Lam KO; Liu TS; Park YS; Sriuranpong V; Sudoyo AW; Wang JY; Zhang J; Zhang SZ; Ciardiello F; Köhne CH; Shaw M; Kim TW
Clin Colorectal Cancer; 2014 Sep; 13(3):145-55. PubMed ID: 25209093
[TBL] [Abstract][Full Text] [Related]
38. Clinical use of monoclonal antibodies to the epidermal growth factor receptor in colorectal cancer.
Burtness B
Oncology (Williston Park); 2007 Jul; 21(8):964-70; discussion 970, 974, 976-7. PubMed ID: 17715697
[TBL] [Abstract][Full Text] [Related]
39. Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab.
Garibaldi DC; Adler RA
Ophthalmic Plast Reconstr Surg; 2007; 23(1):62-3. PubMed ID: 17237696
[TBL] [Abstract][Full Text] [Related]
40. Sequential or combination chemotherapy for a patient with mCRC?
Arnold D
Cancer Treat Rev; 2008; 34 Suppl 2():S12-6. PubMed ID: 19101403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
